ArticlePloS one2015
Endovascular Management of Post-Irradiated Carotid Blowout Syndrome.
Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 70 citations in OpenAlex.
- Successful prevention of carotid artery rupture by placing a covered stent before salvage resection of advanced recurrent tongue cancer: a case report.BMC surgery · 2026Article
- A case of carotid blowout syndrome following endoscopic endonasal surgery and proton beam therapy for chondrosarcoma: Considering the role of nasoseptal mucosal flap for minimizing bleeding.Surgical neurology international · 2026Article
- Comparison of Prophylactic Endovascular Treatments for Threatened or Impending Internal/Common Carotid Artery Blowout Syndrome.AJNR. American journal of neuroradiology · 2025Article
- Interventional Treatment Strategies for Carotid Blowout Syndrome After Radiotherapy for Nasopharyngeal Carcinoma.Cancer management and research · 2025Article
- Where and How Should Interventional Radiologists Treat for Carotid Blowout Syndrome Patients?Cardiovascular and interventional radiology · 2024Article
- The Clinical Outcome of Carotid Blowout Syndrome Showing Non-bleeding Angiography.Cardiovascular and interventional radiology · 2024Observational
- Incidence of Carotid Blowout Syndrome in Patients with Head and Neck Cancer after Radiation Therapy: A Cohort Study.Diagnostics (Basel, Switzerland) · 2024Article
- Endovascular Treatment for Primary Tumor Hemorrhage in Oropharyngeal Carcinoma: A Report of Two Cases.Cureus · 2024Article
- Exposed Embolic Coils Observed in a 64-Year-Old Male With Head and Neck Cancer Following Transarterial Embolization for Carotid Blowout Syndrome.Case reports in oncological medicine · 2024Article
- Efficacy analysis of endovascular treatment for ruptured internal carotid artery pseudoaneurysm hemorrhage in patients with nasopharyngeal carcinoma after radiotherapy.Frontiers in surgery · 2024Article
- Surgical treatment of carotid blowout syndrome after radiotherapy for head and neck malignant tumors: a single-center experience.Neurosurgical review · 2023Article
- Deconstructive vs. reconstructive endovascular treatment paradigms in acute carotid blowout.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2023Article
- Endovascular Treatment of Visceral Artery Pseudoaneurysms with Ethylene-Vinyl Alcohol (EVOH) Copolymer-Based Non-Adhesive Liquid Embolic Agents (NALEAs).Medicina (Kaunas, Lithuania) · 2023Article
- Transcatheter Arterial Embolization (TAE) of Cancer-Related Bleeding.Medicina (Kaunas, Lithuania) · 2023Article
- Management of double carotid blowout with definitive repair after temporizing stent graft placement.Journal of vascular surgery cases and innovative techniques · 2022Article
- Risk factors for rebleeding and long-term outcomes in patients with head and neck cancer bleeding: a multicenter study.BMC cancer · 2022Article
- Heparin-bonded stent graft placement for treatment of massive epistaxis from ruptured radiation-induced internal carotid artery pseudoaneurysm: A case report.Radiology case reports · 2022Article
- Recurrent Carotid artery blow out in a head & neck patient.International journal of surgery case reports · 2022Article
- Risk factors of recurrent carotid blowout syndrome and strategy of endovascular management.Journal of the Chinese Medical Association : JCMA · 2022Article
- Prevention and early management of carotid blowout syndrome for patients receiving head and neck salvage boron neutron capture therapy (BNCT).Journal of dental sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo retrospectively evaluate the clinical and technical factors related to the outcomes of endovascular management in patients with head-and-neck cancers associated with post-irradiated carotid blowout syndrome (PCBS). MATERIALS AND
methodsBetween 2000 and 2013, 96 patients with PCBS underwent endovascular management. The 40 patients with the pathological lesions located in the external carotid artery were classified as group 1 and were treated with embolization. The other 56 patients with the pathological lesions located in the trunk of the carotid artery were divided into 2 groups as follows: group 2A comprised the 38 patients treated with embolization, and group 2B comprised the 18 patients treated with stent-graft placement. Fisher's exact test was used to examine endovascular methods, clinical severities, and postprocedural clinical diseases as predictors of outcomes.
resultsTechnical success and immediate hemostasis were achieved in all patients. The results according to endovascular methods (group 1 vs 2A vs 2B) were as follows: technical complication (1/40[2.5%] vs 9/38[23.7%] vs 9/18[50.0%], P = 0.0001); rebleeding (14/40[35.0%] vs 5/38[13.2%] vs 7/18[38.9%]), P = 0.0435). The results according to clinical severity (acute vs ongoing PCBS) were as follows: technical complication (15/47[31.9%] vs 4/49[8.2%], P = 0.0035); rebleeding (18/47[38.3%] vs 8/49[16.3%], P = 0.0155). The results according to post-procedural clinical disease (regressive vs progressive change) were as follows: alive (14/21[66.7%] vs 8/75[10.7%], P<0.0001); survival time (34.1±30.6[0.3-110] vs 3.6±4.0[0.07-22] months, P<0.0001).
conclusionThe outcomes of endovascular management of PCBS can be improved by taking embolization as a prior way of treatment, performing endovascular intervention in slight clinical severity and aggressive management of the post-procedural clinical disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.